Pub Date : 2026-01-28DOI: 10.1016/j.ajpath.2025.11.012
M D Imam Uddin, John S Penn
Under diabetic conditions, hyperglycemia significantly disrupts oxygen metabolism, leading to widespread retinal hypoxia that affects all retinal cell types. The human retina is structurally complex, comprising multiple layers of metabolically active cells. Diabetic retinas are especially vulnerable to tissue oxygen pressure fluctuations, making them more susceptible to hypoxia-related damage. We have found that diabetic retinas experience hyperglycemia induced retinal hypoxia. Early detection of retinal hypoxia could improve outcomes in diabetic retinopathy (DR) and help prevent irreversible vision loss. However, conventional imaging tools such as optical coherence tomography and fluorescein angiography lack the sensitivity to detect hypoxic changes before permanent irreparable damage occurs. This review explores emerging technologies aimed at detecting (i) retinal hypoxia, and also (ii) vascular oxygenation, as two separate imaging objectives. It highlights Dr. Robert Linsenmeier's pioneering work using invasive microelectrodes to map oxygen distribution across retinal layers and focuses on the development of HYPOX-4, a novel, highly sensitive molecular imaging probe for detecting hypoxia in the living diabetic retinas. Additionally, this review provides an overview of other emerging technologies for imaging oxygenation in the diabetic retina, including retinal oximetry, phosphorescence lifetime imaging, functional MRI and photoacoustic imaging, which may collectively enhance our understanding and management of DR.
{"title":"Retinal hypoxia is an early detection imaging biomarker for diabetic retinopathy.","authors":"M D Imam Uddin, John S Penn","doi":"10.1016/j.ajpath.2025.11.012","DOIUrl":"https://doi.org/10.1016/j.ajpath.2025.11.012","url":null,"abstract":"<p><p>Under diabetic conditions, hyperglycemia significantly disrupts oxygen metabolism, leading to widespread retinal hypoxia that affects all retinal cell types. The human retina is structurally complex, comprising multiple layers of metabolically active cells. Diabetic retinas are especially vulnerable to tissue oxygen pressure fluctuations, making them more susceptible to hypoxia-related damage. We have found that diabetic retinas experience hyperglycemia induced retinal hypoxia. Early detection of retinal hypoxia could improve outcomes in diabetic retinopathy (DR) and help prevent irreversible vision loss. However, conventional imaging tools such as optical coherence tomography and fluorescein angiography lack the sensitivity to detect hypoxic changes before permanent irreparable damage occurs. This review explores emerging technologies aimed at detecting (i) retinal hypoxia, and also (ii) vascular oxygenation, as two separate imaging objectives. It highlights Dr. Robert Linsenmeier's pioneering work using invasive microelectrodes to map oxygen distribution across retinal layers and focuses on the development of HYPOX-4, a novel, highly sensitive molecular imaging probe for detecting hypoxia in the living diabetic retinas. Additionally, this review provides an overview of other emerging technologies for imaging oxygenation in the diabetic retina, including retinal oximetry, phosphorescence lifetime imaging, functional MRI and photoacoustic imaging, which may collectively enhance our understanding and management of DR.</p>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146091653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.1016/j.ajpath.2025.12.014
Ushasree Pattamatta, Melanie Qin, Nicole Carnt, Andrew White
Organotypic retinal explant cultures are a valuable experimental tool for investigating neuroretinal diseases and advancing therapeutic strategies. Ex vivo methods preserve the natural architecture and intercellular interactions of the retina while enabling precise manipulations of the microenvironment, a distinct advantage over traditional in vitro two-dimensional cell models. Compared with in vivo animal and human studies, retinal explants offer ethical and cost-effective advantages, serving as bridge models for both animal to human and preclinical to clinical studies. This review explores the application of retinal explants in retinal disease research, covering emerging technologies, specific neurodegenerative diseases, human explants, and future directions. Technologies including gene therapy, electrophysiology, live imaging, stem cell transplantation, nanoparticle delivery, optogenetics, and artificial intelligence exhibit ready integrated into explant models and rapid advancement. Although retinal explants do not replicate the full systemic context of the eye, they represent powerful localized models for efficient study of retinal physiology and pathophysiology. With these advantages, retinal explants can be used as a translational platform capable of accelerating the development and validation of retinal therapies.
{"title":"Organotypic Retinal Explant Culture as a Model for Neuroretinal Degenerative Disease and Future Applications.","authors":"Ushasree Pattamatta, Melanie Qin, Nicole Carnt, Andrew White","doi":"10.1016/j.ajpath.2025.12.014","DOIUrl":"10.1016/j.ajpath.2025.12.014","url":null,"abstract":"<p><p>Organotypic retinal explant cultures are a valuable experimental tool for investigating neuroretinal diseases and advancing therapeutic strategies. Ex vivo methods preserve the natural architecture and intercellular interactions of the retina while enabling precise manipulations of the microenvironment, a distinct advantage over traditional in vitro two-dimensional cell models. Compared with in vivo animal and human studies, retinal explants offer ethical and cost-effective advantages, serving as bridge models for both animal to human and preclinical to clinical studies. This review explores the application of retinal explants in retinal disease research, covering emerging technologies, specific neurodegenerative diseases, human explants, and future directions. Technologies including gene therapy, electrophysiology, live imaging, stem cell transplantation, nanoparticle delivery, optogenetics, and artificial intelligence exhibit ready integrated into explant models and rapid advancement. Although retinal explants do not replicate the full systemic context of the eye, they represent powerful localized models for efficient study of retinal physiology and pathophysiology. With these advantages, retinal explants can be used as a translational platform capable of accelerating the development and validation of retinal therapies.</p>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146046081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-22DOI: 10.1016/j.ajpath.2026.01.002
Rui Zhu, Guijie Jiang, Jie Shen, Chengxuan Gong, Hongyu Shan, Tingming Liang, Li Guo
Metastasis is a major threat in breast cancer, often involving lymph node (LN) dissemination. However, the cellular composition and signaling networks within the metastatic microenvironment remain incompletely characterized, resulting in limited understanding of the molecular mechanisms driving LN metastasis. In this study, a comprehensive single-cell atlas of metastatic niches was constructed using single-cell RNA-sequencing data from 78 primary breast tumors and their paired LN metastatic samples. Among the epithelial cell subpopulations, distinct clusters representing early-disseminated cancer cells were identified. Notably, profound metabolic reprogramming and immune modulation was observed during the malignant transformation of epithelial cells, which may contribute to the invasive and metastatic phenotype of early-disseminated cancer cells. Furthermore, the communication network within the metastatic microenvironment has also been delineated systematically, where crosstalk among lymphocyte, macrophage, and epithelial cells drove immunosuppressive features of LN metastasis. To explore potential therapeutic interventions, computational drug repositioning was conducted and four tyrosine kinase receptor inhibitors were identified that may target key interactions within this crosstalk. These results were validated using spatial transcriptomics data of four metastatic LN tissue sections from an integrated single-cell RNA-sequencing cohort. Collectively, this study discussed the cellular architecture and regulatory interplay underlying LN metastasis in breast cancer, offering novel insights that may inform targeted therapeutic strategies for patients with metastatic disease.
{"title":"Deciphering the Cellular and Metabolic Landscape of Lymph Node Metastasis in Breast Cancer Using Single-Cell and Spatial Multi-Omics.","authors":"Rui Zhu, Guijie Jiang, Jie Shen, Chengxuan Gong, Hongyu Shan, Tingming Liang, Li Guo","doi":"10.1016/j.ajpath.2026.01.002","DOIUrl":"10.1016/j.ajpath.2026.01.002","url":null,"abstract":"<p><p>Metastasis is a major threat in breast cancer, often involving lymph node (LN) dissemination. However, the cellular composition and signaling networks within the metastatic microenvironment remain incompletely characterized, resulting in limited understanding of the molecular mechanisms driving LN metastasis. In this study, a comprehensive single-cell atlas of metastatic niches was constructed using single-cell RNA-sequencing data from 78 primary breast tumors and their paired LN metastatic samples. Among the epithelial cell subpopulations, distinct clusters representing early-disseminated cancer cells were identified. Notably, profound metabolic reprogramming and immune modulation was observed during the malignant transformation of epithelial cells, which may contribute to the invasive and metastatic phenotype of early-disseminated cancer cells. Furthermore, the communication network within the metastatic microenvironment has also been delineated systematically, where crosstalk among lymphocyte, macrophage, and epithelial cells drove immunosuppressive features of LN metastasis. To explore potential therapeutic interventions, computational drug repositioning was conducted and four tyrosine kinase receptor inhibitors were identified that may target key interactions within this crosstalk. These results were validated using spatial transcriptomics data of four metastatic LN tissue sections from an integrated single-cell RNA-sequencing cohort. Collectively, this study discussed the cellular architecture and regulatory interplay underlying LN metastasis in breast cancer, offering novel insights that may inform targeted therapeutic strategies for patients with metastatic disease.</p>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146043632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-22DOI: 10.1016/j.ajpath.2025.12.013
Stefan Filges, Emma Jonasson, Maria Del Carmen Leiva Arrabal, Lisa Andersson, Anna Gustafsson, Dalia Dhingra, Pedro Mendez, Aik Ooi, Adam Sciambi, Göran Landberg, David Ruff, Anders Ståhlberg
Cellular heterogeneity plays a critical role in tissues and diseases, including cancer. Single-cell technologies are required to provide detailed information about the phenotype and genotype of individual cells. Despite several approaches to analyzing different analytes at the single-cell level, it is challenging to assess DNA, RNA, and protein simultaneously. Here, a single-cell triomics method to assess DNA, RNA, and proteins from the same cell using a targeted sequencing approach is shown. Breast cancer cells cultured in monolayers and in patient-derived scaffolds that mimic in vivo-like growth conditions, both with and without chemotherapy treatment, were analyzed. Data showed that DNA, RNA, and protein biomarkers could be reliably analyzed, providing biological insights into breast cancer cell heterogeneity. In addition, chemotherapy treatment caused changes in subpopulations and expressions of biomarkers. Furthermore, cells growing in patient-derived scaffolds generated from various breast cancers affected cell heterogeneity and drug resistance differently as a result of the unique tumor-specific microenvironments. The data show that single-cell triomics provides new means to assess cancer cell heterogeneity at DNA, RNA, and protein levels.
{"title":"Single-Cell Triomics Analysis of Tumor Cells Infiltrating Patient-Derived Breast Cancer Scaffolds.","authors":"Stefan Filges, Emma Jonasson, Maria Del Carmen Leiva Arrabal, Lisa Andersson, Anna Gustafsson, Dalia Dhingra, Pedro Mendez, Aik Ooi, Adam Sciambi, Göran Landberg, David Ruff, Anders Ståhlberg","doi":"10.1016/j.ajpath.2025.12.013","DOIUrl":"10.1016/j.ajpath.2025.12.013","url":null,"abstract":"<p><p>Cellular heterogeneity plays a critical role in tissues and diseases, including cancer. Single-cell technologies are required to provide detailed information about the phenotype and genotype of individual cells. Despite several approaches to analyzing different analytes at the single-cell level, it is challenging to assess DNA, RNA, and protein simultaneously. Here, a single-cell triomics method to assess DNA, RNA, and proteins from the same cell using a targeted sequencing approach is shown. Breast cancer cells cultured in monolayers and in patient-derived scaffolds that mimic in vivo-like growth conditions, both with and without chemotherapy treatment, were analyzed. Data showed that DNA, RNA, and protein biomarkers could be reliably analyzed, providing biological insights into breast cancer cell heterogeneity. In addition, chemotherapy treatment caused changes in subpopulations and expressions of biomarkers. Furthermore, cells growing in patient-derived scaffolds generated from various breast cancers affected cell heterogeneity and drug resistance differently as a result of the unique tumor-specific microenvironments. The data show that single-cell triomics provides new means to assess cancer cell heterogeneity at DNA, RNA, and protein levels.</p>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146043659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-20DOI: 10.1016/j.ajpath.2025.10.008
Hannah R. Hrncir , Brianna Goodloe , Sergei Bombin , Siyang J. Sun , Zelin Zhang , Anant Madabhushi , Adam D. Gracz
Intrahepatic bile ducts (IHBDs) form a complex hierarchical network essential for liver function. The remodeling and expansion of this network during ductular reaction (DR) are hallmarks of liver disease that can be key indicators of disease severity. Conventional histology fails to capture the full extent of IHBD structural changes after injury due to the complex three-dimensional (3D) organization of the IHBD network that limits understanding of DR, especially in human tissue. A major barrier to leveraging 3D imaging as a diagnostic tool is the absence of standardized pipelines for IHBD imaging and analysis. This work establishes a robust 3D IHBD imaging and analysis workflow, applying it to both mouse and human liver tissues. This pipeline enables quantification of tissue and individual duct (“segment”) level features and identifies features of invasive and noninvasive DR. In mouse models, we uncover regional phenotypes, including IHBD diverticula-like structures after duct blockage and the formation of anastomosed clusters after hepatocellular injury. Finally, this 3D imaging and analysis workflow is applied to quantify IHBD networks in human liver tissue. This work deepens our understanding of IHBD architecture in homeostasis and injury, laying the groundwork for advanced phenotyping of IHBD morphologies in mice and humans with relevance to next-generation experimental and diagnostic approaches to liver disease.
{"title":"Quantitative 3D Imaging of Mouse and Human Intrahepatic Bile Ducts in Homeostasis and Liver Injury","authors":"Hannah R. Hrncir , Brianna Goodloe , Sergei Bombin , Siyang J. Sun , Zelin Zhang , Anant Madabhushi , Adam D. Gracz","doi":"10.1016/j.ajpath.2025.10.008","DOIUrl":"10.1016/j.ajpath.2025.10.008","url":null,"abstract":"<div><div>Intrahepatic bile ducts (IHBDs) form a complex hierarchical network essential for liver function. The remodeling and expansion of this network during ductular reaction (DR) are hallmarks of liver disease that can be key indicators of disease severity. Conventional histology fails to capture the full extent of IHBD structural changes after injury due to the complex three-dimensional (3D) organization of the IHBD network that limits understanding of DR, especially in human tissue. A major barrier to leveraging 3D imaging as a diagnostic tool is the absence of standardized pipelines for IHBD imaging and analysis. This work establishes a robust 3D IHBD imaging and analysis workflow, applying it to both mouse and human liver tissues. This pipeline enables quantification of tissue and individual duct (“segment”) level features and identifies features of invasive and noninvasive DR. In mouse models, we uncover regional phenotypes, including IHBD diverticula-like structures after duct blockage and the formation of anastomosed clusters after hepatocellular injury. Finally, this 3D imaging and analysis workflow is applied to quantify IHBD networks in human liver tissue. This work deepens our understanding of IHBD architecture in homeostasis and injury, laying the groundwork for advanced phenotyping of IHBD morphologies in mice and humans with relevance to next-generation experimental and diagnostic approaches to liver disease.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 445-459"},"PeriodicalIF":3.6,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145996377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-20DOI: 10.1016/j.ajpath.2025.09.009
Blandine Baffert , Kevin Schneider , Audrey Wetzel , Ludivine Dal Zuffo , Cécile Chagué , Eléa Mitifiot , Francis Bonnefoy , Alicja Kuzniewska , Philippe Saas , Jamal Bamoulid , Gwenael Rolin , Sylvain Perruche , Sanja Arandjelovic
Macrophages are critical regulators of inflammation with an essential role in maintaining and re-establishing homeostasis after inflammatory insults. However, excessive macrophage activation could promote fibrosis, highlighting their potential as a therapeutic target in chronic inflammatory diseases. Two preclinical models of systemic sclerosis, bleomycin-induced systemic scleroderma and sclerodermatous graft-versus-host disease, were used to analyze the role of macrophages in the establishment of fibrosis. In both models, macrophage numbers increase in the skin and lungs, in association with elevated collagen content and correlating with fibrosis development. These macrophages had a Ly6clowCD206+MerTk+ phenotype, suggesting a profibrotic role during disease progression. Using macrophage depletion and differentiation blocking approaches, this work shows that reduced macrophage accumulation effectively prevented bleomycin-induced fibrosis development. Direct profibrotic activity of bleomycin-exposed macrophages was revealed by s.c. macrophage injections in naïve mice, which was sufficient to induce systemic fibrosis. Finally, bleomycin-treated primary mouse and human macrophages display reduced clearance of apoptotic cells and secrete factors that promote fibroblast activation and collagen production. Metabolic and mitochondrial dysfunction, changes in receptor shedding, and cytoskeletal reorganization in bleomycin-treated macrophages further contribute to their impaired efferocytosis and enhanced profibrotic activity. Collectively, this work identifies macrophages as critical promoters of tissue fibrosis and suggests that inhibition of macrophage activation represents a new potent therapeutic avenue in efforts to reverse fibrosis associated with chronic inflammation.
{"title":"Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model","authors":"Blandine Baffert , Kevin Schneider , Audrey Wetzel , Ludivine Dal Zuffo , Cécile Chagué , Eléa Mitifiot , Francis Bonnefoy , Alicja Kuzniewska , Philippe Saas , Jamal Bamoulid , Gwenael Rolin , Sylvain Perruche , Sanja Arandjelovic","doi":"10.1016/j.ajpath.2025.09.009","DOIUrl":"10.1016/j.ajpath.2025.09.009","url":null,"abstract":"<div><div>Macrophages are critical regulators of inflammation with an essential role in maintaining and re-establishing homeostasis after inflammatory insults. However, excessive macrophage activation could promote fibrosis, highlighting their potential as a therapeutic target in chronic inflammatory diseases. Two preclinical models of systemic sclerosis, bleomycin-induced systemic scleroderma and sclerodermatous graft-<em>versus</em>-host disease, were used to analyze the role of macrophages in the establishment of fibrosis. In both models, macrophage numbers increase in the skin and lungs, in association with elevated collagen content and correlating with fibrosis development. These macrophages had a Ly6c<sup>low</sup>CD206<sup>+</sup>MerTk<sup>+</sup> phenotype, suggesting a profibrotic role during disease progression. Using macrophage depletion and differentiation blocking approaches, this work shows that reduced macrophage accumulation effectively prevented bleomycin-induced fibrosis development. Direct profibrotic activity of bleomycin-exposed macrophages was revealed by s.c. macrophage injections in naïve mice, which was sufficient to induce systemic fibrosis. Finally, bleomycin-treated primary mouse and human macrophages display reduced clearance of apoptotic cells and secrete factors that promote fibroblast activation and collagen production. Metabolic and mitochondrial dysfunction, changes in receptor shedding, and cytoskeletal reorganization in bleomycin-treated macrophages further contribute to their impaired efferocytosis and enhanced profibrotic activity. Collectively, this work identifies macrophages as critical promoters of tissue fibrosis and suggests that inhibition of macrophage activation represents a new potent therapeutic avenue in efforts to reverse fibrosis associated with chronic inflammation.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 460-478"},"PeriodicalIF":3.6,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145996366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-20DOI: 10.1016/j.ajpath.2025.10.013
Madiha Zahra Syeda , Emily S.H. Yeung , Lisa Y.Q. Hong , Suzanne L. Advani , Youan Liu , Laurette Geldenhuys , Ferhan S. Siddiqi , Veera Ganesh Yerra , Sri Nagarjun Batchu , Andrew Advani
Recent years have seen substantial scientific excitement in the role that the double-stranded DNA sensor and mediator of inflammation, stimulator of interferon genes (STING), plays in kidney disease. However, the STING pathway is not the sole regulator of inflammation, and STING has roles other than in inflammation. Here, elevated STING levels were observed in both human and mouse kidney disease, and the effects of STING deletion from kidney tubule cells, myeloid cells, and globally in experimental kidney disease were examined. Inflammatory gene up-regulation in tubule cells, induced by double-stranded DNA, was attenuated (but not negated) by STING knockout. Either myeloid or global knockout of STING marginally diminished fibroinflammatory gene up-regulation in mice with kidney injury caused by unilateral ureteral obstruction, whereas tubule cell knockout of STING unexpectedly augmented inflammatory gene up-regulation. Global knockout of STING similarly worsened diabetic kidney disease, likely due to heightened hyperglycemia. Antagonism of STING attenuated autophagy induction in human tubule cells, but not in human glomerular endothelial cells or podocytes. These findings serve as a counterweight to the enthusiasm that has recently emerged as to the roles of STING-mediated signaling in kidney disease. The actions of STING extend beyond its role in inflammation, and they are cell type dependent. STING may be a fine-tuner, but it is unlikely to be a prime mover, of inflammation in kidney disease.
{"title":"Stimulator of Interferon Genes Is a Fine-Tuner, but Not a Prime Mover, of Kidney Inflammation","authors":"Madiha Zahra Syeda , Emily S.H. Yeung , Lisa Y.Q. Hong , Suzanne L. Advani , Youan Liu , Laurette Geldenhuys , Ferhan S. Siddiqi , Veera Ganesh Yerra , Sri Nagarjun Batchu , Andrew Advani","doi":"10.1016/j.ajpath.2025.10.013","DOIUrl":"10.1016/j.ajpath.2025.10.013","url":null,"abstract":"<div><div>Recent years have seen substantial scientific excitement in the role that the double-stranded DNA sensor and mediator of inflammation, stimulator of interferon genes (STING), plays in kidney disease. However, the STING pathway is not the sole regulator of inflammation, and STING has roles other than in inflammation. Here, elevated STING levels were observed in both human and mouse kidney disease, and the effects of STING deletion from kidney tubule cells, myeloid cells, and globally in experimental kidney disease were examined. Inflammatory gene up-regulation in tubule cells, induced by double-stranded DNA, was attenuated (but not negated) by STING knockout. Either myeloid or global knockout of STING marginally diminished fibroinflammatory gene up-regulation in mice with kidney injury caused by unilateral ureteral obstruction, whereas tubule cell knockout of STING unexpectedly augmented inflammatory gene up-regulation. Global knockout of STING similarly worsened diabetic kidney disease, likely due to heightened hyperglycemia. Antagonism of STING attenuated autophagy induction in human tubule cells, but not in human glomerular endothelial cells or podocytes. These findings serve as a counterweight to the enthusiasm that has recently emerged as to the roles of STING-mediated signaling in kidney disease. The actions of STING extend beyond its role in inflammation, and they are cell type dependent. STING may be a fine-tuner, but it is unlikely to be a prime mover, of inflammation in kidney disease.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 515-531"},"PeriodicalIF":3.6,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145996367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-20DOI: 10.1016/j.ajpath.2025.09.008
XiangHua Han, Jennifer M. Caron, Peter C. Brooks
The ability of the immune system to control malignant tumors depends in part on the migratory ability of CD8+ T cells. Developing in-depth cellular and molecular understanding into how changes in the structural organization of collagen-IV differentially governs site-specific CD8+ T-cell migration through restrictive tissue barriers is challenging given the dynamic biomechanical alterations occurring in the basement membranes of tumor blood vessels. Thus, uncovering new mechanisms regulating CD8+ T-cell migration through structurally altered or denatured collagen-IV may allow the development of clinically useful strategies to selectively enhance immune cell infiltration of tumors in a context-dependent manner. This work provides evidence that a secreted RGDKGE-containing collagen peptide limits CD8+ T-cell migration on denatured forms of collagen-IV, but not on normal triple helical collagen-IV by a unique mechanism. This novel pathway involves the context-dependent regulation of myosin IXB (MYO9B) and Yes-associated protein-1 (YAP) in CD8+ T cells, ultimately leading to altered F-actin polarization and selectively reduced migration on denatured collagen-IV that is enriched in basement membranes of tumor vessels. In addition to defining a previously unknown mechanism that contributes to the site-specific control of CD8+ T-cell migration, these studies provide a strategy to selectively reverse the inhibitory effects of this endogenously secreted collagen peptide using a function-blocking antibody, resulting in enhanced accumulation of CD8+ T cells in tumors growing in vivo.
{"title":"Inhibiting the Secreted RGDKGE Collagen Peptide Selectively Controls CD8+ T-Cell Migration on Denatured Collagen-IV and Enhances Their Accumulation in Tumors","authors":"XiangHua Han, Jennifer M. Caron, Peter C. Brooks","doi":"10.1016/j.ajpath.2025.09.008","DOIUrl":"10.1016/j.ajpath.2025.09.008","url":null,"abstract":"<div><div>The ability of the immune system to control malignant tumors depends in part on the migratory ability of CD8<sup>+</sup> T cells. Developing in-depth cellular and molecular understanding into how changes in the structural organization of collagen-IV differentially governs site-specific CD8<sup>+</sup> T-cell migration through restrictive tissue barriers is challenging given the dynamic biomechanical alterations occurring in the basement membranes of tumor blood vessels. Thus, uncovering new mechanisms regulating CD8<sup>+</sup> T-cell migration through structurally altered or denatured collagen-IV may allow the development of clinically useful strategies to selectively enhance immune cell infiltration of tumors in a context-dependent manner. This work provides evidence that a secreted RGDKGE-containing collagen peptide limits CD8<sup>+</sup> T-cell migration on denatured forms of collagen-IV, but not on normal triple helical collagen-IV by a unique mechanism. This novel pathway involves the context-dependent regulation of myosin IXB (MYO9B) and Yes-associated protein-1 (YAP) in CD8<sup>+</sup> T cells, ultimately leading to altered F-actin polarization and selectively reduced migration on denatured collagen-IV that is enriched in basement membranes of tumor vessels. In addition to defining a previously unknown mechanism that contributes to the site-specific control of CD8<sup>+</sup> T-cell migration, these studies provide a strategy to selectively reverse the inhibitory effects of this endogenously secreted collagen peptide using a function-blocking antibody, resulting in enhanced accumulation of CD8<sup>+</sup> T cells in tumors growing <em>in vivo</em>.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 598-617"},"PeriodicalIF":3.6,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145996368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1016/j.ajpath.2025.12.009
Hui Li, Murong Ma, Wen Wen, Mariah R Leidinger, Di Hu, Zuohui Zhang, Hong Lin, Jia Luo
Acute pancreatitis (AP) is a common, potentially severe inflammatory disease of the pancreas. Although environmental triggers such as alcohol and gallstones are well known, only a subset of exposed individuals develop AP, suggesting that genetic or intrinsic factors contribute to disease onset and severity. Endoplasmic reticulum (ER) stress has emerged as a key pathogenic mechanism in AP due to the essential role of the ER in protein synthesis, folding, and degradation (proteostasis). Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an ER stress-inducible protein highly expressed in the pancreas and critical for proteostasis, but its role in AP remains unclear. To investigate this, pancreas-specific Manf knockout mice were generated using the Cre/loxP system and subjected them to caerulein- or alcohol-induced AP. In both models, MANF deficiency worsened pancreatic injury, as evidenced by elevated ER stress markers [phosphorylated eukaryotic initiation factor 2 alpha (p-eIF2α) and glucose-regulated protein 78 (GRP78)], apoptosis (cleaved caspase-3), inflammation (IL-6 and tumor necrosis factor α), regeneration (Ki67), and elevated pancreatic lipase levels. In the caerulein model, male Manf knockout mice exhibited higher oxidative stress and macrophage infiltration than female mice. In the alcohol model, both sexes showed increased inflammation and macrophage infiltration, but oxidative stress and high mobility group box 1 expression were again more prominent in male mice. These findings suggest that MANF contributes to pancreatic resilience under stress conditions and may influence sex-dependent responses during AP.
{"title":"Deficiency of Mesencephalic Astrocyte-Derived Neurotrophic Factor Aggravates Acute Pancreatitis in Mice.","authors":"Hui Li, Murong Ma, Wen Wen, Mariah R Leidinger, Di Hu, Zuohui Zhang, Hong Lin, Jia Luo","doi":"10.1016/j.ajpath.2025.12.009","DOIUrl":"10.1016/j.ajpath.2025.12.009","url":null,"abstract":"<p><p>Acute pancreatitis (AP) is a common, potentially severe inflammatory disease of the pancreas. Although environmental triggers such as alcohol and gallstones are well known, only a subset of exposed individuals develop AP, suggesting that genetic or intrinsic factors contribute to disease onset and severity. Endoplasmic reticulum (ER) stress has emerged as a key pathogenic mechanism in AP due to the essential role of the ER in protein synthesis, folding, and degradation (proteostasis). Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an ER stress-inducible protein highly expressed in the pancreas and critical for proteostasis, but its role in AP remains unclear. To investigate this, pancreas-specific Manf knockout mice were generated using the Cre/loxP system and subjected them to caerulein- or alcohol-induced AP. In both models, MANF deficiency worsened pancreatic injury, as evidenced by elevated ER stress markers [phosphorylated eukaryotic initiation factor 2 alpha (p-eIF2α) and glucose-regulated protein 78 (GRP78)], apoptosis (cleaved caspase-3), inflammation (IL-6 and tumor necrosis factor α), regeneration (Ki67), and elevated pancreatic lipase levels. In the caerulein model, male Manf knockout mice exhibited higher oxidative stress and macrophage infiltration than female mice. In the alcohol model, both sexes showed increased inflammation and macrophage infiltration, but oxidative stress and high mobility group box 1 expression were again more prominent in male mice. These findings suggest that MANF contributes to pancreatic resilience under stress conditions and may influence sex-dependent responses during AP.</p>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145996986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15DOI: 10.1016/j.ajpath.2025.12.010
Ning Li, Yunyu Feng, Nan Wang, Wei He, Hongjian Li, Xue Cui, Bochuan Wang, Runkuan Qin, Huandi Qiu, Qiang Qiu, Li Zheng, Yuanyuan Sun, Linye He, Cong Pan, Anping Su, Zhihui Li, Yiguo Hu
Hematopoietic stem cell (HSC) aging leads to hematological dysfunction and diseases, but the regulatory factors involved remain incompletely characterized. In this study, the HSC Aging-Associated TFs Catalog System model was developed to identify transcription factors (TFs) that resist HSC aging. This approach revealed RORA as a key aging-negative-associated TF. Rora deletion in HSCs caused aged phenomes and functionally impaired their reconstitutive capacity. Additionally, Rora deficiency impaired leukemia stem cell proliferation and prevented chronic myelogenous leukemia. These findings establish RORA as a critical regulator in maintaining HSC function and provide insights into its therapeutic potential in hematological disorders.
{"title":"Rora Regulates Hematopoietic Stem Cell Phenotypes and Progression of Chronic Myelogenous Leukemia.","authors":"Ning Li, Yunyu Feng, Nan Wang, Wei He, Hongjian Li, Xue Cui, Bochuan Wang, Runkuan Qin, Huandi Qiu, Qiang Qiu, Li Zheng, Yuanyuan Sun, Linye He, Cong Pan, Anping Su, Zhihui Li, Yiguo Hu","doi":"10.1016/j.ajpath.2025.12.010","DOIUrl":"10.1016/j.ajpath.2025.12.010","url":null,"abstract":"<p><p>Hematopoietic stem cell (HSC) aging leads to hematological dysfunction and diseases, but the regulatory factors involved remain incompletely characterized. In this study, the HSC Aging-Associated TFs Catalog System model was developed to identify transcription factors (TFs) that resist HSC aging. This approach revealed RORA as a key aging-negative-associated TF. Rora deletion in HSCs caused aged phenomes and functionally impaired their reconstitutive capacity. Additionally, Rora deficiency impaired leukemia stem cell proliferation and prevented chronic myelogenous leukemia. These findings establish RORA as a critical regulator in maintaining HSC function and provide insights into its therapeutic potential in hematological disorders.</p>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145994223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}